# EPIRUS Biopharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/epirus-biopharmaceuticals

- Industry: Biotechnology
- Headquarters: Boston, US
- Website: www.epirusbiopharma.com
- Total disclosed funding: $36M
- Latest round: Series B (Apr 16, 2014)
- Investors on record: 9

## About

Epirus is a US-based company that focuses on the development of biosimilar products.

## Funding rounds

- Series B, Apr 16, 2014, $36M — Montreux Equity Partners, Mousse Partners, 5AM Ventures, Adage Capital Management, TPG Biotech, Monashees, Greenwoods Capital Partners, Livzon Mabpharm, Inc., Gibralt US, Inc.

## Investors

- Montreux Equity Partners (https://capitalatlas.ai/funds/montreux-equity-partners) — Series B
- Mousse Partners — Series B
- 5AM Ventures (https://capitalatlas.ai/funds/5am-ventures) — Series B
- Adage Capital Management — Series B
- TPG Biotech (https://capitalatlas.ai/funds/tpg-biotech) — Series B
- Monashees (https://capitalatlas.ai/funds/monashees) — Series B
- Greenwoods Capital Partners (https://capitalatlas.ai/funds/greenwoods-capital-partners) — Series B
- Livzon Mabpharm, Inc. — Series B
- Gibralt US, Inc. — Series B